Jane Street’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Jane Street’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,150	Closed	-$254K	–	9928
2024 Q3	$254K	Buy	+10,150	New	+$254K	﹤0.01%	8295
2024 Q2	–	Sell	-18,756	Closed	-$480K	–	9737
2024 Q1	$480K	Buy	18,756 +1,092	+6%	+$28.1K	﹤0.01%	6746
2023 Q4	$463K	Buy	17,664 +1,976	+13%	+$42.9K	﹤0.01%	6889
2023 Q3	$329K	Buy	+15,688	New	+$364K	﹤0.01%	6928

Other funds holding IBRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Jane Street's IBRN Position: Q4 2024 in Review

Jane Street sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q4 2024, closing a stake of 10,150 shares — an estimated $254K sold.

Jane Street first reported a position in IBRN in Q3 2023 and held it in 4 quarters. The position peaked at $480K in Q1 2024. 2 funds tracked by Wall St. Rank hold IBRN as of Q4 2024.

Jane Street reported no remaining iShares Neuroscience and Healthcare ETF position as of Q4 2024 after selling out during the quarter.
Jane Street sold 10,150 iShares Neuroscience and Healthcare ETF shares in Q4 2024, an estimated $254K.
Jane Street first reported a position in iShares Neuroscience and Healthcare ETF in Q3 2023 and held it in 4 quarters.
Jane Street's iShares Neuroscience and Healthcare ETF position peaked at $480K in Q1 2024.
2 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.